Cargando…

PEGylated Domain I of Beta-2-Glycoprotein I Inhibits the Binding, Coagulopathic, and Thrombogenic Properties of IgG From Patients With the Antiphospholipid Syndrome

APS is an autoimmune disease in which antiphospholipid antibodies (aPL) cause vascular thrombosis and pregnancy morbidity. In patients with APS, aPL exert pathogenic actions by binding serum beta-2-glycoprotein I (β2GPI) via its N-terminal domain I (DI). We previously showed that bacterially-express...

Descripción completa

Detalles Bibliográficos
Autores principales:	McDonnell, Thomas C. R., Willis, Rohan, Pericleous, Charis, Ripoll, Vera M., Giles, Ian P., Isenberg, David. A., Brasier, Allan R., Gonzalez, Emilio B., Papalardo, Elizabeth, Romay-Penabad, Zurina, Jamaluddin, Mohammad, Ioannou, Yiannis, Rahman, Anisur
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204385/ https://www.ncbi.nlm.nih.gov/pubmed/30405613 http://dx.doi.org/10.3389/fimmu.2018.02413

Ejemplares similares

PEGylated Domain I of Beta-2-Glycoprotein I Inhibits Thrombosis in a Chronic Mouse Model of the Antiphospholipid Syndrome
por: Willis, Rohan, et al.
Publicado: (2022)

Antibodies to domain I of β-2-glycoprotein I and IgA antiphospholipid antibodies in patients with ‘seronegative’ antiphospholipid syndrome
por: Cousins, Laura, et al.
Publicado: (2015)

Antiphospholipid Antibodies to Domain I of Beta-2-Glycoprotein I Show Different Subclass Predominance in Comparison to Antibodies to Whole Beta-2-glycoprotein I
por: McDonnell, Thomas, et al.
Publicado: (2018)

Proof-of-concept study demonstrating the pathogenicity of affinity-purified IgG antibodies directed to domain I of β(2)-glycoprotein I in a mouse model of anti-phospholipid antibody-induced thrombosis
por: Pericleous, Charis, et al.
Publicado: (2015)

Anti-factor Xa antibodies in patients with antiphospholipid syndrome and their effects upon coagulation assays
por: Artim-Esen, Bahar, et al.
Publicado: (2015)

Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome
por: Pericleous, Charis, et al.
Publicado: (2016)

Oxidation of β2-glycoprotein I associates with IgG antibodies to domain I in patients with antiphospholipid syndrome
por: Raimondo, Maria Gabriella, et al.
Publicado: (2017)

Factor Xa Mediates Calcium Flux in Endothelial Cells and is Potentiated by Igg From Patients With Lupus and/or Antiphospholipid Syndrome
por: Artim-Esen, Bahar, et al.
Publicado: (2017)

Antiphospholipid antibodies enhance rat neonatal cardiomyocyte apoptosis in an in vitro hypoxia/reoxygenation injury model via p38 MAPK
por: Bourke, Lauren T, et al.
Publicado: (2017)

Antiphospholipid antibody levels in early systemic lupus erythematosus: are they associated with subsequent mortality and vascular events?
por: Pericleous, Charis, et al.
Publicado: (2020)

Novel Assays of Thrombogenic Pathogenicity in the Antiphospholipid Syndrome Based on the Detection of Molecular Oxidative Modification of the Major Autoantigen β(2)-Glycoprotein I
por: Ioannou, Yiannis, et al.
Publicado: (2011)

Development of a high yield expression and purification system for Domain I of Beta-2-glycoprotein I for the treatment of APS
por: McDonnell, Thomas, et al.
Publicado: (2015)

Purified IgG from Patients with Obstetric but not IgG from Non-obstetric Antiphospholipid Syndrome Inhibit Trophoblast Invasion
por: Poulton, Katie, et al.
Publicado: (2015)

Antiphospholipid antibody positivity in early systemic lupus erythematosus is associated with subsequent vascular events
por: Farina, Nicola, et al.
Publicado: (2022)

Gene expression profiling identifies distinct molecular signatures in thrombotic and obstetric antiphospholipid syndrome
por: Ripoll, Vera M., et al.
Publicado: (2018)

Evaluating the conformation of recombinant domain I of β(2)-glycoprotein I and its interaction with human monoclonal antibodies
por: Pericleous, Charis, et al.
Publicado: (2011)

Interactions of human monoclonal and polyclonal antiphospholipid antibodies with serine proteases involved in hemostasis
por: Lambrianides, Anastasia, et al.
Publicado: (2011)

Domain I of β2GPI is capable of blocking serum IgA antiphospholipid antibodies binding in vitro: an effect enhanced by PEGylation
por: Albay, A, et al.
Publicado: (2019)

PEGylated drugs in rheumatology—why develop them and do they work?
por: McDonnell, Thomas, et al.
Publicado: (2014)

The role of beta-2-glycoprotein I in health and disease associating structure with function: More than just APS
por: McDonnell, Thomas, et al.
Publicado: (2020)

Serum nitrated nucleosome levels in patients with systemic lupus erythematosus: a retrospective longitudinal cohort study
por: Croca, Sara, et al.
Publicado: (2014)

A novel expression system of domain I of human beta2 glycoprotein I in Escherichia coli
por: Ioannou, Yiannis, et al.
Publicado: (2006)

Hydroxychloroquine as an Immunomodulatory and Antithrombotic Treatment in Antiphospholipid Syndrome
por: Arachchillage, Deepa J., et al.
Publicado: (2023)

Determination of Thrombogenicity Levels of Various Antiphospholipid Antibodies by a Modified Thrombin Generation Assay in Patients with Suspected Antiphospholipid Syndrome
por: Bradáčová, Pavla, et al.
Publicado: (2022)

Safety of percutaneous tracheostomy in coagulopathic patients
por: Myatra, S, et al.
Publicado: (2006)

Going viral in rheumatology: using social media to show that mechanistic research is relevant to patients with lupus and antiphospholipid syndrome
por: McDonnell, Thomas C R, et al.
Publicado: (2018)

The Differences Between Childhood and Adult Onset Antiphospholipid Syndrome
por: Wincup, Chris, et al.
Publicado: (2018)

Approach to the Coagulopathic Patient in the Intensive Care Unit
por: Singh, Manoj Yogendra
Publicado: (2019)

Percutaneous Tracheostomy in Coagulopathic Patients: Proceed with Caution
por: Divatia, Jigeeshu V
Publicado: (2020)

Incidence of Antiphospholipid Syndrome: Is Estimation Currently Possible?
por: Ioannou, Yiannis, et al.
Publicado: (2023)

Metastatic coagulopathic subdural hematoma: A dismal prognosis
por: George, Kuriakose J., et al.
Publicado: (2012)

Perioperative Considerations in Management of the Severely Bleeding Coagulopathic Patient
por: Erdoes, Gabor, et al.
Publicado: (2023)

Damage accrual and mortality over long-term follow-up in 300 patients with systemic lupus erythematosus in a multi-ethnic British cohort
por: Segura, Beatriz Tejera, et al.
Publicado: (2019)

Damage accrual and mortality over long-term follow-up in 300 patients with systemic lupus erythematosus in a multi-ethnic British cohort
por: Segura, Beatriz Tejera, et al.
Publicado: (2019)

Recombinant Factor VIIa: Hemostatic Adjunct in the Coagulopathic Burn Patient
por: Martin, Jeremiah T., et al.
Publicado: (2009)

Portuguese Consensus and Recommendations for Acquired Coagulopathic Bleeding Management (CCBM)
por: Gomes, Manuela, et al.
Publicado: (2021)

Non‐coagulopathic hemothorax in a dog: A case report
por: LaVine, Danielle, et al.
Publicado: (2022)

Device Thrombogenicity Emulation: An In Silico Predictor of In Vitro and In Vivo Ventricular Assist Device Thrombogenicity
por: Chiu, Wei Che, et al.
Publicado: (2019)

IgG anti-apolipoprotein A-1 antibodies in patients with systemic lupus erythematosus are associated with disease activity and corticosteroid therapy: an observational study
por: Croca, Sara, et al.
Publicado: (2015)

Autoimmune rheumatic disease IgG has differential effects upon neutrophil integrin activation that is modulated by the endothelium
por: Khawaja, Akif A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7p3kban8be8gvjr0vgoflei1o7